Silynxcom (SYNX) VP reports holdings of vested stock options in Form 3

Rhea-AI Filing Summary

Silynxcom Ltd. executive Ronen Hananis filed an initial Form 3 showing his holdings of vested stock options. He holds three grants of share options to buy up to 582, 28,456 and 109,081 ordinary shares at exercise prices of $6.01, $1.27 and $1.37 per share, expiring in 2028. These options were granted between 2018 and 2023 and became fully vested between 2020 and 2026.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Hananis Ronen

Role VP of Operations & Development

Type	Security	Shares	Price	Value
holding	Share options (right to buy)	--	--	--
holding	Share options (right to buy)	--	--	--
holding	Share options (right to buy)	--	--	--

Holdings After Transaction: Share options (right to buy) — 582 shares (Direct)

Footnotes (1)

1. The options were granted on March 18, 2018 and became fully vested as of March 18, 2020. The options were granted on March 18, 2018 and became fully vested as of March 18, 2021. The options were granted on January 1, 2023 and became fully vested as of January 1, 2026.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hananis Ronen

(Last) (First) (Middle)

7 GIBOREI ISRAEL

(Street)

NETANYA 4250407

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Silynxcom Ltd. [ SYNX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP of Operations & Development

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share options (right to buy)(1)	03/18/2018	03/18/2028	Ordinary Shares, no par value per share	582	$6.01	D
Share options (right to buy)(2)	03/18/2018	03/18/2028	Ordinary Shares, no par value per share	28,456	$1.27	D
Share options (right to buy)(3)	01/01/2023	01/01/2028	Ordinary Shares, no par value per share	109,081	$1.37	D

Explanation of Responses:

1. The options were granted on March 18, 2018 and became fully vested as of March 18, 2020.

2. The options were granted on March 18, 2018 and became fully vested as of March 18, 2021.

3. The options were granted on January 1, 2023 and became fully vested as of January 1, 2026.

	/s/ Ronen Hananis	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Silynxcom (SYNX) Form 3 filing by Ronen Hananis show?

The Form 3 shows VP of Operations & Development Ronen Hananis holding vested stock options in Silynxcom. These options give him the right to buy ordinary shares at preset prices before their expiration in 2028, outlining his existing derivative equity position.

How many Silynxcom (SYNX) shares can Ronen Hananis buy under his options?

Ronen Hananis holds options over three blocks of underlying shares: 582, 28,456 and 109,081 ordinary shares. Each block is tied to a specific exercise price and expiration date, defining his potential future share ownership if he chooses to exercise.

What are the exercise prices of the Silynxcom options reported in this Form 3?

The reported share options allow purchases of Silynxcom ordinary shares at $6.01, $1.27 and $1.37 per share. These fixed exercise prices determine what Hananis would pay per share if he exercises the options before their respective 2028 expiration dates.

When did the Silynxcom (SYNX) options held by Ronen Hananis fully vest?

The footnotes state that the options granted in March 2018 became fully vested by March 2020 and March 2021, while options granted on January 1, 2023 became fully vested on January 1, 2026. Vesting means the options are now fully exercisable.

Do the Silynxcom Form 3 entries show any recent insider buying or selling?

No buy or sell transactions are reported; the Form 3 lists holdings of existing options. The transaction summary shows zero buys and zero sells, indicating this filing is an initial ownership statement rather than a record of recent trading activity.

What are the expiration dates of the Silynxcom options reported by Ronen Hananis?

The options with exercise prices of $6.01 and $1.27 expire on March 18, 2028, while the options with a $1.37 exercise price expire on January 1, 2028. After these dates, unexercised options will lapse.